Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Meiling She

1PUBLICATIONS

9CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 03, 2024

FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells.

Meng Zhang, Xiaoqi Zeng, Meiling She

Pageof 1

Frequent Collaborators

1 joint publications

Meng Zhang

1 joint publications

Xiaoqi Zeng

1 joint publications

Xingduo Dong

1 joint publications

Jun Chen

1 joint publications

Qingquan Xiong

1 joint publications

Guobin Qiu

1 joint publications

Shuyi Yang

1 joint publications

Xiangqi Li

1 joint publications

Guanghui Ren

Frequent Collaborators

1 joint publications

Meng Zhang

1 joint publications

Xiaoqi Zeng

1 joint publications

Xingduo Dong

1 joint publications

Jun Chen

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos